Literature DB >> 6704308

Excess risk of breast cancer in the mothers of children with soft tissue sarcomas.

J M Birch, A L Hartley, H B Marsden, M Harris, R Swindell.   

Abstract

Information was obtained on the health status or cause of death in the mothers of a population-based series of 143 children with soft tissue sarcomas. Among these mothers there were 6 cases of breast cancer. All 6 women were pre-menopausal and 2 had bilateral disease. This represents a significant 3-fold excess risk of breast cancer. Malignant disease had occurred in 6 other women whose ages at diagnosis ranged from 33 to 58 years. This was not significantly in excess of expectation. The incidence of cancer among mothers of various sub-groups of children was computed. For breast cancer mothers of: boys, children who were less than the median age at diagnosis, and children who had pelvic tumours had a greater excess risk than the group as a whole. Among those sub-groups of mothers the highest excess risk was 13.5. For other cancers, no sub-group showed an incidence which was significantly above the expected. A high proportion of infiltrating lobular carcinoma was found among the breast cancers, and histological type may indicate familial disease. These findings are consistent with the cancer family syndrome described by Li & Fraumeni in 1969, but the present results suggest that a higher proportion of childhood soft tissue sarcoma than was hitherto suspected may have a genetic aetiology. Further pedigree and laboratory studies may help to identify familial cases at the time of the child's diagnosis.

Entities:  

Mesh:

Year:  1984        PMID: 6704308      PMCID: PMC1976735          DOI: 10.1038/bjc.1984.51

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  16 in total

1.  Letter: Familial breast cancer, soft-tissue sarcomas, and other neoplasms.

Authors:  F P Li; J F Fraumen
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

2.  Bilateral breast cancer, clinical and pathological review.

Authors:  G G Finney; G G Finney; A C Montague; G L Stonesifer; C C Brown
Journal:  Ann Surg       Date:  1972-05       Impact factor: 12.969

3.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

4.  Chromosome studies in a "cancer family".

Authors:  R H Bottomley; A L Trainer; P T Condit
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

5.  Genealogy of cancer in a family.

Authors:  W A Blattner; D B McGuire; J J Mulvihill; B C Lampkin; J Hananian; J F Fraumeni
Journal:  JAMA       Date:  1979-01-19       Impact factor: 56.272

6.  Tubular carcinoma: a variant of secretory breast carcinoma.

Authors:  V Eusebi; C M Betts; G Bussolati
Journal:  Histopathology       Date:  1979-09       Impact factor: 5.087

7.  Transmission of in-vitro radioresistance in a cancer-prone family.

Authors:  N T Bech-Hansen; W A Blattner; B M Sell; E A McKeen; B C Lampkin; J F Fraumeni; M C Paterson
Journal:  Lancet       Date:  1981-06-20       Impact factor: 79.321

8.  Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma.

Authors:  H T Lynch; G M Mulcahy; R E Harris; H A Guirgis; J F Lynch
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

9.  Methods of classifying and ascertaining children's tumours.

Authors:  I Leck; J M Birch; H B Marsden; J K Steward
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

10.  Incidence of malignant disease in childhood: a 24-year review of the Manchester Children's Tumour Registry data.

Authors:  J M Birch; H B Marsden; R Swindell
Journal:  Br J Cancer       Date:  1980-08       Impact factor: 7.640

View more
  16 in total

Review 1.  Advances in managing childhood cancer.

Authors:  P M Jones
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-04

Review 2.  Li-Fraumeni syndrome--a molecular and clinical review.

Authors:  J M Varley; D G Evans; J M Birch
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Mutations in CHEK2 associated with prostate cancer risk.

Authors:  Xiangyang Dong; Liang Wang; Ken Taniguchi; Xianshu Wang; Julie M Cunningham; Shannon K McDonnell; Chiping Qian; Angela F Marks; Susan L Slager; Brett J Peterson; David I Smith; John C Cheville; Michael L Blute; Steve J Jacobsen; Daniel J Schaid; Donald J Tindall; Stephen N Thibodeau; Wanguo Liu
Journal:  Am J Hum Genet       Date:  2003-01-17       Impact factor: 11.025

4.  Childhood predictive genetic testing for Li-Fraumeni syndrome.

Authors:  D G Evans; P Lunt; T Clancy; R Eeles
Journal:  Fam Cancer       Date:  2009-04-30       Impact factor: 2.375

5.  Adrenal cortical tumours: epidemiological and familial aspects.

Authors:  A L Hartley; J M Birch; H B Marsden; H Reid; M Harris; V Blair
Journal:  Arch Dis Child       Date:  1987-07       Impact factor: 3.791

Review 6.  Li-Fraumeni Syndrome.

Authors:  Hernán Correa
Journal:  J Pediatr Genet       Date:  2016-04-13

7.  Malignant melanoma in families of children with osteosarcoma, chondrosarcoma, and adrenal cortical carcinoma.

Authors:  A L Hartley; J M Birch; H B Marsden; M Harris
Journal:  J Med Genet       Date:  1987-11       Impact factor: 6.318

8.  Elevated breast cancer risk among mothers of a population-based series of 2668 children with cancer.

Authors:  D Pang; G Evans; J Birch
Journal:  Ecancermedicalscience       Date:  2008-01-17

9.  An estimate of the heritable fraction of childhood cancer.

Authors:  S A Narod; C Stiller; G M Lenoir
Journal:  Br J Cancer       Date:  1991-06       Impact factor: 7.640

Review 10.  Assessment of environmental and genetic factors in the etiology of childhood cancers: the Childrens Cancer Group epidemiology program.

Authors:  L L Robison; J D Buckley; G Bunin
Journal:  Environ Health Perspect       Date:  1995-09       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.